Rob Califf returns to lead the FDA as the U.S. continues to cope with the pandemic and opioid epidemic. The agency also is facing questions about its processes for accelerated drug approvals.
https://ift.tt/OixZjwR
from WebMD Health https://ift.tt/toy1dDM
by
Comments
Post a Comment